Brief: Bayer Canada and Diagnos join efforts against diabetes
06/12/2016 15:02
Dec 6 (Reuters) - Diagnos Inc ADK.V :
* Says announces pilot project contract for diabetic macular
edema and diabetic retinopathy screening with Bayer Canada
* Screening will be offered to diabetics affiliated to their
health entities to test impact of including preventive screening
programs
* Says under terms of agreement, Diagnos will provide a
fully turn-key screening service to benefit one thousand
diabetic patients in Toronto area
Source text for Eikon: urn:newsml:reuters.com:*:nMKWYvQtKa
Further company coverage: ADK.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Diagnos
See all newsBrief: Diagnos Submits Modified And Updated Health Canada Licence Application For Cara System Platform
Brief: Diagnos To Submit Future CARA Version To FDA Before End Of Q3
Brief: Diagnos Welcomes Dr. Pierre-Luc Charlebois To Its Advisory Board
Brief: Validated For Global Scale Diagnos Passes Annual MDSAP Audit, Solidifying The Pathway To Approvals With Health Canada & FDA
Brief: Diagnos Provides Update On Its Health Canada Medical Device Licence Application